chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was vaccinated without incident on March 23rd, had normal reaction of chills the night after vaccination but otherwise uneventful. On about April 14th I started developing severe hives all over my body. They would flare up in patches on my legs, trunk, arms, and back, then disappear, then reappear again throughout the day. I tried treating them with OTC antihistamines (benadryl, Zyrtec) with little to no relief. After a few days I visited an urgent care who prescribed a short duration of prednisone. The hives temporarily went away, but as soon as the course was done the hives returned in force, along with angioedema of my face (eyelids, lips). I visited a primary care doctor who gave me a shot of steroids (dex?) and referred me to an allergist. The allergist prescribed 4x daily 2nd gen antihistamines (I took fexofenadine 180 mg) and 2x H2 blocker antihistamines (famotidine 20mg).  After 6 weeks with minimal improvement my doctor started me on Xolair 300mg monthly. First dose was June 3 Rd. I've seen progressive improvement on Xolair but still need to take 4x antihistamines + famotidine to keep hives away. I still have occasional flares.
A non-serious report of stiff back, stiff neck and fever was received from a consumer concerning a 10-year-old female.  The patient has a cochlear implant.  No concomitant medications were reported.  The patient received FLUMIST vaccine on 03-Oct-2007.  On 05-Oct-2007 the patient experienced fever of up to 103 degrees Fahrenheit, stiff back and stiff neck.  The patient's pediatrician ruled out meningitis.  By 08-Oct-2007, all symptoms have resolved and the patient went to school that day without any problems.  The reporter did not provide a statement of causality for the adverse events.  The reporting source of this case is spontaneous, thus the sponsor's comment is not applicable.
Patient was given 5-11 dose of Pfizer and should have been given 12+ dose.  Patient has had no adverse reactions, wrong dose was given.
BELL'S PALSY; This spontaneous report received from a patient concerned a 62 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-alcohol user, non-smoker, diabetes type 2, and hypertension. The patient had no known allergies. The patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: UNKNOWN) dose was not reported, 1 total administered to left arm on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 21-APR-2021, the patient experienced drooping of the face and was unable to close his right eye. On the same day, the patient went to the emergency room and was discharged the same day with a diagnosis of Bell's Palsy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bell's palsy on 15-JUN-2021. This report was serious (Other Medically Important Condition). Sender's Comments: V0: 20220233633-COVID-19 VACCINE AD26.COV2.S-bell's palsy. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Loss of hair in large patches, two this far. Completely bald spots; This is a spontaneous report from a contactable consumer. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included zolpidem tartrate (AMBIEN) received within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 24Apr2021, the patient experienced loss of hair in large patches and there was two patches which were completely bald at the time of report. The clinical outcome of the event loss of hair in large patches and there was two patches which were completely bald was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from an office manager refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 06-JUN-2014, the patient was vaccinated with (Oka/Merck) VARIVAX 0.5ml, intramuscular. Lot number and expiration date were not reported. On 06-JUN-2014, the patient received improperly stored (Oka/Merck) VARIVAX exposed to 15F for 86 hours. No adverse event were reported. This is one of several reports from the same source. Additional information has been requested.
Insomnia; Insomnia is accelerating symptoms (childhood asthmatic, obese, history of hbp, smoker); Insomnia is accelerating symptoms (childhood asthmatic, obese, history of hbp, smoker); Insomnia is accelerating symptoms (childhood asthmatic, obese, history of hbp, smoker); Insomnia is accelerating symptoms (childhood asthmatic, obese, history of hbp, smoker); Insomnia is accelerating symptoms (childhood asthmatic, obese, history of hbp, smoker); morning nausea; lost sense of smell; taste loss/sense of taste loss; metallic taste; vertigo; Tinnitus; dizzy; extreme (3x normal) hearing in right ear; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MOD-2023-718503 (Moderna).  A 58-year-old male patient received BNT162b2 (BNT162B2), on 24Aug2021 as dose 1, single (Lot number: fc3183) at the age of 58 years for covid-19 immunisation. The patient's relevant medical history included: "childhood asthmatic" (unspecified if ongoing); "Obesity" (unspecified if ongoing); "Blood pressure high" (unspecified if ongoing); "Smoker" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: TINNITUS (non-serious) with onset 24Aug2021, outcome "recovering"; DIZZINESS (non-serious) with onset 24Aug2021, outcome "recovering", described as "dizzy"; AUDITORY DISORDER (non-serious) with onset 24Aug2021, outcome "recovering", described as "extreme (3x normal) hearing in right ear"; ANOSMIA (non-serious) with onset 27Aug2021, outcome "recovering", described as "lost sense of smell"; DYSGEUSIA (non-serious) with onset 27Aug2021, outcome "recovering", described as "metallic taste"; NAUSEA (non-serious) with onset 27Aug2021, outcome "recovering", described as "morning nausea"; AGEUSIA (non-serious) with onset 27Aug2021, outcome "recovering", described as "taste loss/sense of taste loss"; VERTIGO (non-serious) with onset 27Aug2021, outcome "recovering"; INSOMNIA (non-serious), outcome "recovering"; ASTHMA (non-serious), OBESITY (non-serious), HYPERTENSION (non-serious), TOBACCO USER (non-serious), CONDITION AGGRAVATED (non-serious), outcome "recovering" and all described as "Insomnia is accelerating symptoms (childhood asthmatic, obese, history of hbp, smoker)". Additional information: Long-term effects to Pfizer/BioNTech - 10 mins after receiving Pfizer vaccine 1st dose, 24Aug2021, tinnitus, dizzy, extreme (3x normal) hearing in right ear. On the third morning (27Aug2021) nausea, lost sense of smell, sense of taste loss as well, metallic taste, vertigo. Insomnia is accelerating symptoms (childhood asthmatic, obese, history of hbp, smoker). 20Feb2023 started training 1 hr daily and is helping with recovery.
ONLY THE NORMAL THINGS; This spontaneous report received from a parent concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, (Dose series number : 1) start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced only the normal things. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of only the normal things was not reported. This report was non-serious.
Mild waves of nausea for 24hrs (these began 30 minutes after vaccination and came and went randomly over the next 24hrs), sore arm, 24hrs after the vaccine felt as if coming down with a cold and generally unwell and very tired. These symptoms lasted only about 24-30hrs.
blisters & raised bumps to face-arms-neck sparingly;rx atarax; Caladryl
Patient came in 12/17/19 complaining  of pain after the shot which radiates down his arm and up to his neck sometimes; said it started after he had the shingles vaccine. He did not notice any bruising, just pain.
At 1155AM resident was in dinging room in wheelchair. The resident "slumped over" in her wheelchair with "blank stare and pupils dilated, right side of mouth dropped open and drooling," resident did not respond to verbal or painful stimuli, respirations rapid and shallow, VS: temp97.3 forehead scan, pulse with machine 94 respiration 30, 02 Sat 90% room air, machine will not give BP reading, attempted manual BP and unable to hear any beats, res taken to ER via W/C with 2 staff assist ER Course: Evaluated in ER-
PATIENT SAID HER ARM IS RED DOWN TO HER ELBOW AND THE SKIN IS WARM TO THE TOUCH.
My woke me up at 2:30 a.m. clutching his chest, crying out in pain, saying, ?Mommy, my heart is hurting!? He couldn?t take a deep breath because of the pain. In addition, he reported severe body pain and was sobbing! I rushed him to the ER, where they did a cardiac work-up, which was unremarkable (I.e., no signs of myocarditis or pericarditis). He was given Tylenol and Ibuprofen, which helped reduce the pain. He?s had to have around the clock Tylenol and Ibuprofen since that time to cope with pain. As of last night he seemed to be feeling better and he was able to take deep breaths without pain. I have never seen my son this symptomatic from any illness or vaccine in his entire life! As an aside, he had side effects following the first dose (I.e., body pain, low grade fever, lethargy, loss of appetite). We have a follow-up with his pediatrician today.
Mother reported to school nurse morning of 10/17/18 that patient had a fever of 104 deg F overnight with right arm pain. Fever resolved by morning, denied redness at injection site.
blurry vision; headache; This is a spontaneous report from a contactable consumer (patient) via a medical information team. A 66-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date were not provided), via an unspecified route of administration, on 29Jan2021, at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 29Jan2021, patient had blurry vision and headache. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Soon after injection arm area became red and swollen. Swelling was large enough to cause clothing to be very tight.
Solution came out the side of needle,the needle on the syringe was faulty; didn't receive full booster dose (0.25 ml),liquid came out of injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of SYRINGE ISSUE (Solution came out the side of needle,the needle on the syringe was faulty) and INCORRECT DOSE ADMINISTERED (didn't receive full booster dose (0.25 ml),liquid came out of injection site) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 069F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced SYRINGE ISSUE (Solution came out the side of needle,the needle on the syringe was faulty) and INCORRECT DOSE ADMINISTERED (didn't receive full booster dose (0.25 ml),liquid came out of injection site). On 18-Nov-2021, SYRINGE ISSUE (Solution came out the side of needle,the needle on the syringe was faulty) and INCORRECT DOSE ADMINISTERED (didn't receive full booster dose (0.25 ml),liquid came out of injection site) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.  It was reported that the patient was re vaccinated with Moderna during the same session. The HCP stated that again the patient did not receive the entire 0.25 ml dose as some of the liquid came out of injection site. The HCP also stated that some fluid may have been entered into patients fatty arm tissue.
Doses administered after temperature excursion; Doses administered after temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after temperature excursion) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001J21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2022 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 07-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after temperature excursion). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after temperature excursion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Vaccine was administered on left side intramuscularly.  No concomitant products were reported. No adverse event reported.  No treatment details were reported.  On Monday 07-Feb-2022 at 8:00 am, the digital readout on data logger reading -22.5 degree F for freezer and 19.9 degree F for refrigerator. Vaccine bottles from refrigerator had no signs of freeze, which meant no ice or crystallized solids in the vaccine bottle. The refrigerator temperature controller dial adjusted to 5 from initial number 7. No water bottles in refrigerator and frozen coolant packs in freezer at that time or any other times. At 9:11 am, refrigerator data logger reading was 27.7 degree F. Freezer data logger reading was -10.3 degree F. The temperature controller dial was on number 5. At 9:55 am on 07-FEB-2022, refrigerator data logger reading was 32.5 degree F and freezer data logger reading was -0.9 degree F.
Woke up 12hrs after vaccine with shaking chills in bed at 4am. For the entire day after the vaccine I was unable to do anything except sleep. Had headaches, fatigue, muscle aches, fevers, chills
Information has been received from a pharmacy intern referring to a patient of unknown age and gender. The patient's medical history, concomitant therapy and concurrent condition were not provided. On approximately 13-OCT-2016 (reported as "Thursday or Friday of last week"), the patient was vaccinated with an expired dose of VARIVAX (dose, route and lot number were unknown; expiration date May 2016). No adverse effect was reported. Additional information is not expected as the reporter did not wish to be contacted.
45 patient were vaccinated by vaccine after 39 days storage in refrigerator; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (45 patient were vaccinated by vaccine after 39 days storage in refrigerator) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (45 patient were vaccinated by vaccine after 39 days storage in refrigerator). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (45 patient were vaccinated by vaccine after 39 days storage in refrigerator) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   Reporter did not allow further contact
BREATHING SHALLOW; FEELING BAD; FEELING SICK; FEELS SOMETHING IN THE BACK WHEN TAKES A DEEP BREATH; MUSCLE ACHE; NAUSEA; This spontaneous report received from a patient concerned a 71 year old female. The patient's height, and weight were not reported. The patient's past medical history included stomach ulcers, and concurrent conditions included bad heart condition, and atrial fibrillation.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and expiry: not reported ) dose was not reported, administered on 15-MAR-2021 12:30 for prophylactic vaccination. Concomitant medications included apixaban for drug used for unknown indication, and paracetamol for drug used for unknown indication. On 15-MAR-2021, the subject experienced breathing shallow. On 15-MAR-2021, the subject experienced feeling bad. On 15-MAR-2021, the subject experienced feeling sick. On 15-MAR-2021, the subject experienced feels something in the back when takes a deep breath. On 15-MAR-2021, the subject experienced muscle ache. On 15-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feeling bad, nausea, muscle ache, feeling sick, and breathing shallow, and the outcome of feels something in the back when takes a deep breath was not reported. This report was non-serious.
pt recv vax 15JAN97 & on 29JAN97 pt to ER w/gen skin rash upper torso, malaise, stiffness to hands/wrist;p/eval by MD pt recv DPH & Ibuprofen & instruction to f/u w/pvt MD;
Very sore at injection site (left arm), chills, body aches, sore joints, fever going up and down between 99.0 and 102.0 for 18 hours, headache, sleepiness, loss of appetite, very thirsty
pt recvd vax & exp erythematous rash @ inj site & indurated,reddened,inflamed area @ inj site;sx cont;these sx were noted when pt arrived for 2nd vax,which will probably be deferred until the inflammation resolves;
PT REPORTED ON THE CONSENT FORM THAT THEY WERE 17 YEARS OLD AND REQUESTED A MODERNA BOOSTER, WHERE THEY WERE UNDER AGED, SHOULD HAVE BEEN 18YEARS OLD, WHERE THEY BECAME THE FOLLOWING WEEK.
Patient states that her arm is now bright red where the vaccine was given, and is warm to the touch. She has taken the flu shot every year, but never had a response to it.  She isn't complaining of feeling feverish.
Dizziness, Headache, Myalgia, light headed, sore arm, headache - after 2nd dose Narrative:
Pt went to see MD on 12-24-08 with complaints of rash on neck, trunk and upper arms.  C/o of itching.  Was prescribed Atarax.
severe stomach pain including dry heaving , vomiting, nausea, stomach cramps began approx. 14 hours after shot was received, 16 hours after shot was received the following symptoms occurred: Dizziness,  extreme fatigue (was only awake for approx. 1 hour from the time of onset of symptoms- slept the entire day following shot)  body aches, muscle cramps, vomiting, diarrhea, fever of 102, slurred speech, blurred vision, severe headache. symptoms did not go away until approx 36 hours after shot was recieved- muscle soreless, diahrea, nausea and mild fatigue lingered until late the following day ( more than 24 hours)
Fever, chills, I feel like I have Covid all over again and I know there is no live virus in the vaccine.   I had a positive test on Feb 21, 2021, last fever was on March 2nd
Information regarding PREVNAR 13 was received from a nurse regarding a patient (unknown age and sex) who experienced high fever. The patient received a dose on an unknown date in 2010. The patient experienced high fever on an unknown date in 2010. The patient did not get any vaccines other than PREVNAR 13. The patient had to return to the doctor's office due to the high fever. Treatments are not reported. The outcome of fever is unknown. No additional information was available at the time of this report.
Body aches; Chills; Headaches; Fever; Arm discomfort; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in left arm on 20Mar2021 at 10:00 (at the age of 32 years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes. The patient was not allergic to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not take any other medications within two weeks of vaccination. On 20Mar2021, the patient experienced arm discomfort. On 21Mar2021, at 20:00, the patient experienced chills, body aches, headaches and fever. It was unknown if the patient received treatment for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of arm discomfort, headache and general body pain was resolved on an unknown date in Mar2021. The clinical outcome of the events chills and fever was not resolved at the time of report. No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a registered nurse refers to a patient of unknown age (gender unspecified). On 30-MAY-2013 the patient was vaccinated with an expired PNEUMOVAX23 lot # 671615/1170AA, exp date. 10-MAY-2013, 0.5 ml once, intramuscularly. No adverse effect reported. Additional information has been requested.